Bcl-2和FAS作为亡相关的标记物在状态患者中
Lejla Ćorić1, Slavica Sović2, Brankica Šimac3
1Department of Neurology, Clinical Hospital Dubrava, Referral Centre of the Ministry of Health of the Republic of Croatia for Preoperative Treatment of Patients with Pharmacoresistant Epilepsy, Avenija Gojka Šuška 6, 10000 Zagreb, Croatia.
Journal of clinical medicine
|October 16, 2025
概括
状态 (SE) 涉及明显的亡反应. 脑脊液 (CSF) Bcl-2的增加表明神经保护,而血清FAS的增加表明系统激活,突出显示SE的潜在生物标志物.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 状态 (SE) 是一种关键的神经紧急情况.
- SE与神经元损伤和亡有关,但人类数据很少.
- 亡途径是SE病变发生的关键.
研究的目的:
- 在人类性SE.中研究与亡相关的蛋白Bcl-2和FAS.
- 为了比较SE患者与对照者的血清和脑脊液 (CSF) 水平.
- 评估这些蛋白质在SE病理生理学中的作用.
主要方法:
- 从18名性SE患者和15名对照组收集了血清和脑脊液.
- 不包括患有急性脑损伤,中风,瘤或中枢神经系统感染的患者.
- 在多个时间点使用ELISA量化Bcl-2和FAS.
主要成果:
- 在SE患者中,CSF Bcl-2 水平显著更高 (p < 0.001).
- 脊髓中FAS水平在两组之间没有显著差异 (p = 0.94).
- 在SE患者中,血清FAS在所有时间点都显著升高 (p < 0.001).
结论:
- 性SE在中枢神经系统和外围表现出差异性的亡标志物.
- 增加的CSF Bcl-2可能表明神经保护或压力反应.
- 持续高的血清FAS表明SE的系统性亡激活.
相关概念视频
Seizures: Classification
1.3K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.3K
The Intrinsic Apoptotic Pathway
8.3K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.3K
Epilepsy and Seizures: Overview
1.1K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
814
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
814
Caspases
13.7K
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
13.7K
NF-κB-dependent Signaling Pathway
9.8K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
9.8K


